
Cadosil500 mg
Unimed Unihealth MFG. Ltd.
Calcium Dobesilate is a vasoprotective (angioprotective) agent used in the symptomatic treatment of the following conditions: Established / Widely Approved Uses Chronic venous insufficiency (CVI):…
Calcium Dobesilate is a vasoprotective (angioprotective) agent used in the symptomatic treatment of the following conditions:
Note: Calcium Dobesilate is not approved by the US FDA and is not marketed in the United States; its use is based on approvals and clinical practice in Europe, Latin America, and parts of Asia.
Dosage of Calcium Dobesilate should be individualized by the prescribing physician based on the condition being treated and response to therapy.
| Indication | Typical Adult Dose |
|---|---|
| Chronic venous insufficiency | 500 mg twice daily, may be increased to 500 mg three times daily or 1000 mg twice daily in more severe cases, depending on physician assessment |
| Hemorrhoidal disease (acute episode) | 500 mg to 1000 mg twice daily for a limited course, as advised by the physician |
| Diabetic retinopathy (adjunct, where used) | 500 mg two to three times daily, as part of a physician-directed regimen; not a substitute for standard diabetic eye care |
Doses should not exceed what is prescribed. Treatment duration and re-evaluation should be guided by the physician (see Duration of Treatment).
Calcium Dobesilate is generally well tolerated at recommended doses. Reported side effects include:
Calcium Dobesilate is contraindicated in patients with known hypersensitivity to Calcium Dobesilate or to any component of the formulation.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.